We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $479.38, marking a -0.29% move from the previous day. This change lagged the S&P 500's daily gain of 0.67%. Elsewhere, the Dow gained 0.25%, while the tech-heavy Nasdaq added 1.14%.
Coming into today, shares of the largest U.S. health insurer had lost 5.36% in the past month. In that same time, the Medical sector gained 0.27%, while the S&P 500 lost 0.73%.
UnitedHealth Group will be looking to display strength as it nears its next earnings release. On that day, UnitedHealth Group is projected to report earnings of $6.36 per share, which would represent year-over-year growth of 9.84%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $91.44 billion, up 13.03% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $24.83 per share and revenue of $367.84 billion, which would represent changes of +11.9% and +13.47%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. UnitedHealth Group is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, UnitedHealth Group is holding a Forward P/E ratio of 19.36. This represents a premium compared to its industry's average Forward P/E of 15.51.
It is also worth noting that UNH currently has a PEG ratio of 1.41. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs was holding an average PEG ratio of 1.06 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 55, which puts it in the top 22% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $479.38, marking a -0.29% move from the previous day. This change lagged the S&P 500's daily gain of 0.67%. Elsewhere, the Dow gained 0.25%, while the tech-heavy Nasdaq added 1.14%.
Coming into today, shares of the largest U.S. health insurer had lost 5.36% in the past month. In that same time, the Medical sector gained 0.27%, while the S&P 500 lost 0.73%.
UnitedHealth Group will be looking to display strength as it nears its next earnings release. On that day, UnitedHealth Group is projected to report earnings of $6.36 per share, which would represent year-over-year growth of 9.84%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $91.44 billion, up 13.03% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $24.83 per share and revenue of $367.84 billion, which would represent changes of +11.9% and +13.47%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. UnitedHealth Group is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, UnitedHealth Group is holding a Forward P/E ratio of 19.36. This represents a premium compared to its industry's average Forward P/E of 15.51.
It is also worth noting that UNH currently has a PEG ratio of 1.41. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs was holding an average PEG ratio of 1.06 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 55, which puts it in the top 22% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.